- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/74 - Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Patent holdings for IPC class C07D 213/74
Total number of patents in this class: 1563
10-year publication summary
|
140
|
101
|
90
|
84
|
80
|
98
|
81
|
74
|
65
|
43
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 11016 |
32 |
| Novartis AG | 10263 |
30 |
| Bristol-myers Squibb Company | 4729 |
30 |
| Institut Curie | 615 |
26 |
| Boehringer Ingelheim International GmbH | 4493 |
22 |
| Universite de Montpellier | 1042 |
21 |
| Abivax | 124 |
19 |
| F. Hoffmann-La Roche AG | 7836 |
17 |
| Takeda Pharmaceutical Company Limited | 2715 |
17 |
| Samsung Display Co., Ltd. | 38570 |
16 |
| Celgene Quanticel Research, Inc. | 154 |
14 |
| Genentech, Inc. | 4099 |
13 |
| Oxular Acquisitions Limited | 21 |
13 |
| The Regents of the University of California | 20720 |
12 |
| Abbvie Inc. | 1836 |
12 |
| The Johns Hopkins University | 5875 |
11 |
| Nippon Soda Co., Ltd. | 885 |
11 |
| Janssen Pharmaceutica N.V. | 3171 |
10 |
| Merck Patent GmbH | 5725 |
9 |
| Syngenta Crop Protection AG | 6699 |
9 |
| Other owners | 1219 |